Instant Genius

How psychedelics could kickstart the next mental health revolution

7 snips
Oct 23, 2025
Professor David Nutt, an acclaimed psychopharmacologist from Imperial College London, dives deep into the world of psychedelics and their potential to transform mental health treatment. He discusses how these substances affect the brain, fostering flexibility and altering perceptions. Nutt explores the therapeutic use of psychedelics for conditions like depression and PTSD, highlighting their ability to reconnect distant brain regions. He also addresses the risks, the science behind visual hallucinations, and the promising future for psychedelic-assisted therapies.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
INSIGHT

How Ketamine And MDMA Differ From Classic Psychedelics

  • Ketamine and MDMA produce therapeutic effects but differ from classical serotonergic psychedelics.
  • Ketamine increases brain entropy via NMDA blockade, while MDMA primarily reduces fear by releasing serotonin.
INSIGHT

Psychedelics Turn Down Depressive Brain Circuits

  • fMRI showed psilocybin reduces activity in key brain networks rather than increasing overall brain activity.
  • This dampening targets circuits linked to depressive rumination and produces lasting increases in mental flexibility.
INSIGHT

Default Mode Network: The Ego's Conductor

  • Psychedelics suppress the default mode network, the neural substrate of self-referential thought and ego activity.
  • By 'switching off' this network they free the brain to form novel connections and break entrenched thought patterns.
Get the Snipd Podcast app to discover more snips from this episode
Get the app